<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>High plasma levels of total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (tHcy) are a risk factor for <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Because no information on the relationship between <z:hpo ids='HP_0005305'>cerebral vein thrombosis</z:hpo> and <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> is available, a case-control study of 121 patients with a first episode of <z:hpo ids='HP_0005305'>cerebral vein thrombosis</z:hpo> and 242 healthy control subjects was carried out </plain></SENT>
<SENT sid="2" pm="."><plain>Fasting plasma levels of tHcy and their postmethionine load (PML) increments, together with other laboratory markers of <z:hpo ids='HP_0100724'>thrombophilia</z:hpo>, were measured in plasma or DNA </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">Hyperhomocysteinemia</z:e> (high fasting tHcy and/or PML increments) was diagnosed in 33 patients (27%) and 20 control subjects (8%) (odds ratio, 4.2; 95% confidence interval [CI], 2.3-7.6) </plain></SENT>
<SENT sid="4" pm="."><plain>Low levels of serum <z:chebi fb="3" ids="37445">folate</z:chebi> and the 677TT <z:chebi fb="13" ids="29357,29358">methylene</z:chebi> <z:chebi fb="0" ids="20506,26907">tetrahydrofolate</z:chebi> reductase were associated with <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, but in a multivariate model <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> only was associated with an increased risk of <z:hpo ids='HP_0005305'>cerebral vein thrombosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Oral contraceptive intake was associated with the disease with an odds ratio of 6.1 (95% CI, 3.3-11.0) </plain></SENT>
<SENT sid="6" pm="."><plain>The combined presence of the latter and <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> increased the risk of the disease with an odds ratio of 19.5 (95% CI, 5.7-67.3) </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> is associated with a 4-fold increased risk of <z:hpo ids='HP_0005305'>cerebral vein thrombosis</z:hpo>; whether or not its correction with vitamins reduces the risk of the disease remains to be demonstrated </plain></SENT>
</text></document>